NO20044615L - Tropanderivater som CCR5-modulatorer - Google Patents

Tropanderivater som CCR5-modulatorer

Info

Publication number: NO20044615L
Authority: NO; Norway
Prior art keywords: tropane derivatives; ccr5 modulators; ccr5; modulators; tropane
Prior art date: 2002-04-08

Application number

NO20044615A

Other languages

English (en)

Other versions

NO329674B1 (no

Inventor

Anthony Wood

Patricia Ann Basford

Peter Thomas Stephenson

Stefan Colin John Taylor

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-08

Filing date

2004-10-26

Publication date

2004-10-26

2002-04-08 Priority claimed from GBGB0208071.1A external-priority patent/GB0208071D0/en

2003-01-23 Priority claimed from GB0301575A external-priority patent/GB0301575D0/en

2004-10-26 Application filed by Pfizer filed Critical Pfizer

2004-10-26 Publication of NO20044615L publication Critical patent/NO20044615L/no

2010-11-29 Publication of NO329674B1 publication Critical patent/NO329674B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Psychiatry (AREA)
Tropical Medicine & Parasitology (AREA)

NO20044615A 2002-04-08 2004-10-26 Tropanderivater, farmasoytiske sammensetninger og anvendelser NO329674B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0208071.1A GB0208071D0 (en)	2002-04-08	2002-04-08	Tropane derivatives useful in therapy
GB0301575A GB0301575D0 (en)	2003-01-23	2003-01-23	Tropane derivatives useful in therapy
PCT/IB2003/001220 WO2003084954A1 (en)	2002-04-08	2003-03-31	Tropane derivatives as ccr5 modulators

Publications (2)

Publication Number	Publication Date
NO20044615L true NO20044615L (no)	2004-10-26
NO329674B1 NO329674B1 (no)	2010-11-29

Family

ID=28793308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044615A NO329674B1 (no)	2002-04-08	2004-10-26	Tropanderivater, farmasoytiske sammensetninger og anvendelser

Country Status (40)

Country	Link
EP (1)	EP1492789B1 (no)
JP (2)	JP3793200B2 (no)
KR (1)	KR100734685B1 (no)
CN (1)	CN1324025C (no)
AP (1)	AP1789A (no)
AR (1)	AR039383A1 (no)
AT (1)	ATE328882T1 (no)
AU (1)	AU2003214503B2 (no)
BR (1)	BR0309118A (no)
CA (1)	CA2481482C (no)
CR (1)	CR7514A (no)
CU (1)	CU23282A3 (no)
CY (1)	CY1106114T1 (no)
DE (1)	DE60305903T2 (no)
DK (1)	DK1492789T3 (no)
DO (1)	DOP2003000624A (no)
EA (1)	EA007590B1 (no)
ES (1)	ES2263960T3 (no)
GE (1)	GEP20074210B (no)
HN (1)	HN2003000114A (no)
HR (1)	HRP20040940A2 (no)
IL (1)	IL164261A0 (no)
IS (1)	IS2577B (no)
MA (1)	MA27190A1 (no)
MX (1)	MXPA04009220A (no)
MY (1)	MY134223A (no)
NI (1)	NI200300053A (no)
NO (1)	NO329674B1 (no)
NZ (1)	NZ535452A (no)
OA (1)	OA12798A (no)
PA (1)	PA8570801A1 (no)
PE (1)	PE20040082A1 (no)
PL (1)	PL372968A1 (no)
PT (1)	PT1492789E (no)
RS (1)	RS51550B (no)
SI (1)	SI1492789T1 (no)
TN (1)	TNSN04194A1 (no)
TW (1)	TWI280130B (no)
UY (1)	UY27752A1 (no)
WO (1)	WO2003084954A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1492789B1 (en) *	2002-04-08	2006-06-07	Pfizer Limited	Tropane derivatives as ccr5 modulators
US6855724B2 (en)	2002-04-08	2005-02-15	Agouron Pharmaceuticals, Inc.	Tropane derivatives useful in therapy
EP1786816A4 (en)	2003-09-10	2009-11-04	Virochem Pharma Inc	SPIROHYDANTOIN COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
GB0323236D0 (en) *	2003-10-03	2003-11-05	Pfizer Ltd	Chemical compounds
DE602004010708T2 (de) *	2003-10-03	2008-12-04	Pfizer Inc.	Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
TW200533348A (en)	2004-02-18	2005-10-16	Theravance Inc	Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8131026B2 (en)	2004-04-16	2012-03-06	Validity Sensors, Inc.	Method and apparatus for fingerprint image reconstruction
US7751601B2 (en)	2004-10-04	2010-07-06	Validity Sensors, Inc.	Fingerprint sensing assemblies and methods of making
WO2006064340A2 (en) *	2004-12-13	2006-06-22	Pfizer Limited	Process for the preparation of n-acyl beta-aminoaldehydes
WO2008063600A2 (en) *	2006-11-17	2008-05-29	Concert Pharmaceuticals Inc.	Triazolyl tropane derivatives
JP5194105B2 (ja) *	2007-04-13	2013-05-08	ドンファファーマシューティカルカンパニーリミテッド	１−シクロプロピル−６−フルオロ−７−（８−メトキシイミノ−２，６−ジアザ−スピロ［３．４］オクト−６−イル）−４−オキソ−１，４−ジヒドロ−［１，８］ナフチリジン−３−カルボン酸のアスパラギンサン酸塩、その製造方法、およびそれを含む抗菌用薬学組成物
ES2364686T3 (es)	2007-08-27	2011-09-12	Theravance, Inc.	Compuestos de alquil-8-azabiciclo[3.2.1]octano disustituidos como antagonistas del receptor opioide mu.
CN101712679B (zh)	2008-10-08	2013-04-10	中国科学院上海药物研究所	一种酰胺类化合物、其药物组合物及其制备方法和用途
CA2778206A1 (en) *	2009-11-21	2011-05-26	F. Hoffmann-La Roche Ag	Heterocyclic antiviral compounds
KR20120098908A (ko)	2009-12-23	2012-09-05	아이언우드 파마슈티컬스, 인코포레이티드	Ｃｒｔｈ２ 조절제
EA201290852A1 (ru)	2010-04-02	2013-04-30	ФИВКО-1 ЭлЭлСи	Комбинированная терапия, включающая антагонист ccr5, ингибитор протеазы вич-1 и фармакокинетический усилитель
WO2012009137A1 (en)	2010-07-12	2012-01-19	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
WO2012009134A1 (en)	2010-07-12	2012-01-19	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
HUE047354T2 (hu)	2011-05-18	2020-04-28	Vertex Pharmaceuticals Europe Ltd	Ivacaftor deuterizált származékai
WO2013024022A1 (en)	2011-08-12	2013-02-21	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical compositions for treatment of pulmonary hypertension
CN106977511B (zh) *	2011-12-19	2019-04-12	中国科学院上海药物研究所	一种氨基丙基取代托烷胺类化合物、其药物组合物及其制备方法和用途
JP6146990B2 (ja) *	2012-11-16	2017-06-14	コンサートファーマシューティカルズインコーポレイテッド	重水素化されたｃｆｔｒ増強物質
GB201321749D0 (en)	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
GB201321748D0 (en)	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
US10196384B2 (en)	2015-03-31	2019-02-05	Vertex Pharmaceuticals (Europe) Limited	Deuterated CFTR modulators
CA2999529A1 (en)	2015-09-25	2017-03-30	Vertex Pharmaceuticals (Europe) Limited	Deuterated cftr potentiators
JP2017105824A (ja) *	2017-02-10	2017-06-15	コンサートファーマシューティカルズインコーポレイテッド	重水素化されたｃｆｔｒ増強物質
IL305169B2 (en)	2017-12-01	2025-07-01	Vertex Pharma	Processes for making modulators of cystic fibrosis transmembrane conductance regulator
US11649235B2 (en)	2018-03-19	2023-05-16	Emory University	Pan-tropic entry inhibitors
JP6654223B2 (ja) *	2018-08-13	2020-02-26	バーテックスファーマシューティカルズ（ヨーロッパ）リミテッド	重水素化されたｃｆｔｒ増強物質
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20001420A1 (es) *	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
WO2001080106A1 (en) *	2000-04-19	2001-10-25	Satoshi Yamazaki	Advertising-tool distribution method and magnetic recorded medium for the software
RS50904B (sr) *	2000-05-26	2010-08-31	Pfizer Inc.	Derivati tropana i njihova primena
EP1492789B1 (en) *	2002-04-08	2006-06-07	Pfizer Limited	Tropane derivatives as ccr5 modulators

2003
- 2003-03-31 EP EP03710080A patent/EP1492789B1/en not_active Expired - Lifetime
- 2003-03-31 AP APAP/P/2004/003147A patent/AP1789A/en active
- 2003-03-31 NZ NZ535452A patent/NZ535452A/en not_active IP Right Cessation
- 2003-03-31 CA CA002481482A patent/CA2481482C/en not_active Expired - Lifetime
- 2003-03-31 ES ES03710080T patent/ES2263960T3/es not_active Expired - Lifetime
- 2003-03-31 HR HR20040940A patent/HRP20040940A2/hr not_active Application Discontinuation
- 2003-03-31 EA EA200401167A patent/EA007590B1/ru not_active IP Right Cessation
- 2003-03-31 IL IL16426103A patent/IL164261A0/xx unknown
- 2003-03-31 JP JP2003582151A patent/JP3793200B2/ja not_active Expired - Lifetime
- 2003-03-31 PL PL03372968A patent/PL372968A1/xx unknown
- 2003-03-31 SI SI200330319T patent/SI1492789T1/sl unknown
- 2003-03-31 KR KR1020047016104A patent/KR100734685B1/ko not_active Expired - Fee Related
- 2003-03-31 OA OA1200400262A patent/OA12798A/en unknown
- 2003-03-31 GE GEAP8437A patent/GEP20074210B/en unknown
- 2003-03-31 CN CNB03807639XA patent/CN1324025C/zh not_active Expired - Fee Related
- 2003-03-31 RS YUP-888/04A patent/RS51550B/sr unknown
- 2003-03-31 AU AU2003214503A patent/AU2003214503B2/en not_active Ceased
- 2003-03-31 AT AT03710080T patent/ATE328882T1/de active
- 2003-03-31 BR BR0309118-0A patent/BR0309118A/pt not_active IP Right Cessation
- 2003-03-31 DE DE60305903T patent/DE60305903T2/de not_active Expired - Lifetime
- 2003-03-31 WO PCT/IB2003/001220 patent/WO2003084954A1/en not_active Ceased
- 2003-03-31 MX MXPA04009220A patent/MXPA04009220A/es active IP Right Grant
- 2003-03-31 PT PT03710080T patent/PT1492789E/pt unknown
- 2003-03-31 DK DK03710080T patent/DK1492789T3/da active
- 2003-04-04 DO DO2003000624A patent/DOP2003000624A/es unknown
- 2003-04-04 PE PE2003000346A patent/PE20040082A1/es not_active Application Discontinuation
- 2003-04-04 NI NI200300053A patent/NI200300053A/es unknown
- 2003-04-04 MY MYPI20031257A patent/MY134223A/en unknown
- 2003-04-07 AR ARP030101205A patent/AR039383A1/es unknown
- 2003-04-07 HN HN2003000114A patent/HN2003000114A/es unknown
- 2003-04-07 UY UY27752A patent/UY27752A1/es unknown
- 2003-04-07 TW TW092107880A patent/TWI280130B/zh not_active IP Right Cessation
- 2003-04-08 PA PA20038570801A patent/PA8570801A1/es unknown
2004
- 2004-09-16 IS IS7453A patent/IS2577B/is unknown
- 2004-09-29 MA MA27883A patent/MA27190A1/fr unknown
- 2004-10-06 TN TNP2004000194A patent/TNSN04194A1/fr unknown
- 2004-10-07 CR CR7514A patent/CR7514A/es unknown
- 2004-10-07 CU CU20040219A patent/CU23282A3/es unknown
- 2004-10-26 NO NO20044615A patent/NO329674B1/no not_active IP Right Cessation
2006
- 2006-02-03 JP JP2006027537A patent/JP4571078B2/ja not_active Expired - Lifetime
- 2006-07-04 CY CY20061100919T patent/CY1106114T1/el unknown

Also Published As

Publication number	Publication date
RS51550B (sr)	2011-06-30
PL372968A1 (en)	2005-08-08
PE20040082A1 (es)	2004-03-20
JP3793200B2 (ja)	2006-07-05
IS7453A (is)	2004-09-16
UY27752A1 (es)	2003-11-28
TW200403242A (en)	2004-03-01
WO2003084954A1 (en)	2003-10-16
EA007590B1 (ru)	2006-12-29
PA8570801A1 (es)	2004-11-26
ATE328882T1 (de)	2006-06-15
CA2481482C (en)	2009-11-10
ES2263960T3 (es)	2006-12-16
EA200401167A1 (ru)	2005-04-28
TNSN04194A1 (fr)	2007-03-12
HRP20040940A2 (en)	2005-04-30
CN1646526A (zh)	2005-07-27
EP1492789A1 (en)	2005-01-05
JP2005532285A (ja)	2005-10-27
CA2481482A1 (en)	2003-10-16
MA27190A1 (fr)	2005-01-03
AP2004003147A0 (en)	2004-09-30
NZ535452A (en)	2006-11-30
AP1789A (en)	2007-10-05
DE60305903D1 (de)	2006-07-20
HK1076102A1 (en)	2006-01-06
MXPA04009220A (es)	2005-09-30
DK1492789T3 (da)	2006-09-11
BR0309118A (pt)	2005-02-01
SI1492789T1 (sl)	2006-10-31
NI200300053A (es)	2005-11-01
PT1492789E (pt)	2006-09-29
AU2003214503B2 (en)	2008-08-07
DE60305903T2 (de)	2007-03-08
EP1492789B1 (en)	2006-06-07
DOP2003000624A (es)	2003-10-15
RS88804A (sr)	2006-12-15
IL164261A0 (en)	2005-12-18
MY134223A (en)	2007-11-30
JP4571078B2 (ja)	2010-10-27
GEP20074210B (en)	2007-10-10
NO329674B1 (no)	2010-11-29
CR7514A (es)	2004-11-08
IS2577B (is)	2010-02-15
KR20040099420A (ko)	2004-11-26
AU2003214503A1 (en)	2003-10-20
CU23282A3 (es)	2008-06-30
CY1106114T1 (el)	2011-06-08
TWI280130B (en)	2007-05-01
JP2006182784A (ja)	2006-07-13
AR039383A1 (es)	2005-02-16
OA12798A (en)	2006-07-10
KR100734685B1 (ko)	2007-07-02
CN1324025C (zh)	2007-07-04
HN2003000114A (es)	2004-05-05

Publication	Publication Date	Title
DK1492789T3 (da)	2006-09-11	Tropanderivater som CCR5-modulatorer
DK1284974T3 (da)	2004-06-07	Triazolyltropanderivater som CCR5-modulatorer
NO20052739D0 (no)	2005-06-07	CCR5-antagonister som medikamenter
NO20050426L (no)	2005-03-29	Arylkarbonylderivater som terapeutiske midler
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
AU2003253535A1 (en)	2004-03-11	N-4-piperidinyl compounds as ccr5 modulators
NO20055680D0 (no)	2005-12-01	Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20055135D0 (no)	2005-11-02	Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20041317L (no)	2004-06-29	Benzimidazolidinondenvater som muskarine midler
NO20023283D0 (no)	2002-07-05	Flammestopper
DK1611131T3 (da)	2011-01-17	Pyrazolopyridin-derivater
NO20013149D0 (no)	2001-06-22	Piperidiner som CCR5-modulatorer
DK1501826T3 (da)	2007-01-29	Substituerede indoler som alpha-1-agonister
AU2003291630A1 (en)	2004-05-04	Bluetooth transparent bridge
DK1789041T3 (da)	2008-09-08	Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
DK1797042T3 (da)	2009-03-02	Indozolonderivater som 11B-HSD1-inhibitorer
NO20050665L (no)	2005-04-18	Pyrrolidonderivater som MAOE inhibitoere
ATE456558T1 (de)	2010-02-15	Gabanerge modulatoren
NO20044092L (no)	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin
NO20043794L (no)	2004-09-10	Benzensulfonamidderivater som antipsykotiske midler
DE602004014772D1 (de)	2008-08-14	Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors
DK1648882T3 (da)	2008-11-24	3-fluor-piperidiner som NMDA/NR2B-antagonister
NO20021251D0 (no)	2002-03-13	Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
DK1560828T3 (da)	2006-09-04	Imidazoquinolinderivater som adenosin-A3-receptorligander
IL177729A0 (en)	2006-12-31	N-piperidine derivatives as ccr3 modulators

Legal Events

Date	Code	Title	Description
2012-10-22	MM1K	Lapsed by not paying the annual fees